TORONTO, Sept. 28, 2020 /CNW/ - Khiron Life Sciences
Corp. ("Khiron" or the "Company") (TSXV: KHRN), (OTCQX: KHRNF),
(Frankfurt: A2JMZC), a vertically
integrated cannabis leader with core operations in Latin America and Europe, is pleased to announce that
Alvaro Torres, Khiron CEO and
Director, and Chris Naprawa, Khiron
Chairman, will present live at Canaccord Genuity's 2020 Virtual US
Cannabis Symposium on September 30,
2020.
Date: Wednesday, September 30,
2020
Time: 9:30 a.m. EDT
To register contact: Nadine
Miller nmiller@cgf.com
Hosted by Canaccord Genuity, the 2020 Virtual US Cannabis
Symposium is an investor-focused online event that brings together
institutional investors and financial leaders and features publicly
traded company presentations and one-on-one meetings with senior
management teams representing every facet of the cannabis
industry.
Khiron CEO and Director Alvaro
Torres and Khiron Chairman Chris
Naprawa will present and take questions from symposium
attendees in real time, and a recording of the presentation will be
available for those who are not able to join live on the day of the
event.
Recent Company Highlights:
- Became the first company to sell and fill medical cannabis
prescriptions in Peru through
private pharmacies
- Filled over 3,000 medical cannabis prescriptions in
Colombia since receipt of
authorization to manufacture and commercialize high-THC medical
cannabis.
- Received status of National Interest Strategic Project
("PINES") from the Government of Colombia, enabling Khiron to simplify
authorization processes, reduce cost and accelerate time to market
for its services and products for the Colombian market and for
export.
- Entered partnership with Latin
America's largest multi-vertical app platform Rappi to
distribute Khiron's Kuida CBD product portfolio across LatAm. Rappi
has an average of more than 10 million active users monthly
(source: Apptopia), with deliveries for almost 100,000 businesses
in LatAm, including over 13 million deliveries in Colombia alone.
- Expanded reach of Khiron's medical cannabis e-learning platform
to the UK market in partnership with clinician-led Medical Cannabis
Clinicians Society Doctors. Also participating in this program are
members of Project Twenty21, the leading medical cannabis registry
in the UK where Khiron is the exclusive LatAm provider of medical
cannabis to the project.
- Signed distribution deal for Khiron's Kuida CBD product
portfolio with DNO Group, bringing the brand to Hong Kong consumers. DNO Group, a leading APAC
distributor of global brands, provides access to over 50,000 points
of sale throughout the Asian region.
- Launched Dr. Zerenia teleconsultation platform to meet
essential needs of Khiron's patient network in Colombia.
- Delivered first medical cannabis prescriptions for patients
participating in Project Twenty21 in the UK, with over 8,000
registered patients to date and targeting 20,000 by 2021
- Entered the German medical cannabis market through a
comprehensive agreement with Nimbus Health for the import and sale
of Khiron branded medical cannabis product and medical
training.
About Khiron Life Sciences Corp.
Khiron is a
vertically integrated medical and CPG cannabis company with core
operations in Latin America, and
operational activity in Europe and
North America. Khiron is the
leading cannabis company in Colombia and the first company licensed in
Colombia for the cultivation,
production, domestic distribution, and international export of both
low and high THC medical cannabis products. The Company has filled
medical cannabis prescriptions in Peru and has a presence in Mexico, Uruguay, UK, Spain and also in Germany, where it is positioned to begin sales
of medical cannabis.
Leveraging its first-mover advantage, and patient oriented
approach, Khiron combines global scientific expertise, product
innovation, agricultural infrastructure, wholly-owned medical
clinics, and online doctor education programs to drive prescription
and brand loyalty to address priority medical conditions. Its
Wellbeing unit launched the first branded CBD skincare brand in
Colombia, with Kuida™ now marketed
in multiple jurisdictions in Latin
America, the US and UK. The Company is led by Co-founder and
Chief Executive Officer, Alvaro
Torres, together with an experienced and diverse executive
team and Board of Directors.
Visit Khiron online at investors.khiron.ca and on Instagram
@khironlife.
Cautionary Notes
Forward-Looking Statements
This press release may contain certain "forward-looking
information" and "forward-looking statements" within the meaning of
applicable securities legislation. All information contained herein
that is not historical in nature may constitute forward-looking
information. Khiron undertakes no obligation to comment on
analyses, expectations or statements made by third-parties in
respect of Khiron, its securities, or financial or operating
results (as applicable). Although Khiron believes that the
expectations reflected in forward-looking statements in this press
release are reasonable, such forward-looking statement has been
based on expectations, factors and assumptions concerning future
events which may prove to be inaccurate and are subject to numerous
risks and uncertainties, certain of which are beyond Khiron's
control, including the risk factors discussed in Khiron's Annual
Information Form which is available on Khiron's SEDAR profile at
www.sedar.com. The forward-looking information contained in this
press release is expressly qualified by this cautionary statement
and is made as of the date hereof. Khiron disclaims any intention
and has no obligation or responsibility, except as required by law,
to update or revise any forward-looking information, whether as a
result of new information, future events or otherwise.
Neither the TSXV nor its Regulation Services Provider (as that
term is defined in the policies of the TSXV) accepts responsibility
for the adequacy or accuracy of this press release.
Related Links
https://www.khiron.ca/en/home
View original content to download
multimedia:http://www.prnewswire.com/news-releases/khiron-to-present-at-canaccord-genuity-virtual-us-cannabis-symposium-on-september-30th-301138660.html
SOURCE Khiron Life Sciences Corp.